NEUROTROPIC CYTOMEGALOVIRUS DURING IMMUNOSUPPRESSION
免疫抑制期间的神经营养性巨细胞病毒
基本信息
- 批准号:6460671
- 负责人:
- 金额:$ 12.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-04-01 至 2007-03-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS dementia complex B lymphocyte HIV infections Herpesviridae disease SCID mouse athymic mouse cell component structure /function cellular immunity cytomegalovirus disease /disorder model encephalitis helper T lymphocyte immunocytochemistry immunoglobulins immunosuppression neurotropic virus opportunistic infections pathologic process phenotype virus infection mechanism virus load virus replication
项目摘要
Cytomegalovirus (CMV) is an important opportunistic pathogen with an estimated prevalence in the human population of 50-90%. While most immunocompetent individuals do not develop clinical infection, immunosuppressed patients such as those with AIDS or undergoing immunosuppressive therapy open develop debilitating neurological deficits, mental disorders, cognitive impairment, and potentially fatal infection. CMV also may further suppress the immune system and has been suggested as a co-factor in AIDS dementia syndrome. Lack of an appropriate animal model of natural neurotropic CMV infection has limited understanding of virus entry mechanisms and dissemination in brain. The central hypothesis of this proposal is that systemic CMV infection in immunosuppressed patients disseminates to the brain through specific mechanisms in a predictable, localized pattern and is strongly influenced by the competency of host immune disease. The research described below will define the relationship of systemic CMV infection, host immunity and CNS disease. A novel murine model of parenteral CMV inoculation resulting in neurotropic CMV infection will be used to test this hypothesis through4 primary strategies: 1) determine whether severity of mouse immunodeficiency alters susceptibility to neurotropic CMV dissemination, 2) determine if CMV infection of the CNS can occur through hematogenous dissemination through free virus, infected leukocytes, or directly through intra-axonal transport to brain, 3) determine if mice are protected from neurotropic MCMV by adoptive transfer of specific immune lymphoid cell populations, 4.) determine whether adoptive transfer of immune or non-specific immune T cells can reduce or clear established CMV encephalitis. This proposal elucidates the significance of neurotropic CMV as a principal opportunistic CNS pathogen without confounding variables such as co-incident HIV replication and may help to advance the diagnosis and therapy of CMV related encephalitis and AIDS dementia syndrome. Training inherent to the proposal will extend, broaden, and deepen my knowledge of infectious disease pathogenesis and develop intellectual and technical competency in immune modulation crucial to my scientific independence. Training will be performed at Yale University School of Medicine under the mentorship of Anthony van den Pol, PhD, Professor of Neurosurgery, and a senior neuroscientist, Nancy Ruddle, PhD, Professor of Epidemiology and Public Health/Immunobiology and Epidemiology of Microbial Diseases, and world-class immunologist in collaboration with Akiko Iwasaki, PhD, Assistant Professor of Epidemiology/Public Health who has strong research credentials in the mechanism of host immunity to infectious microorganisms.
巨细胞病毒(CMV)是一种重要的机会致病菌,估计在人群中的患病率为50- 90%。虽然大多数免疫活性个体不会发生临床感染,但免疫抑制患者(如患有AIDS或接受免疫抑制治疗的患者)会发生使人衰弱的神经功能缺损、精神障碍、认知障碍和潜在的致命感染。巨细胞病毒还可能进一步抑制免疫系统,并已被认为是艾滋病痴呆综合征的辅助因子。缺乏合适的天然嗜神经性CMV感染的动物模型限制了对病毒进入脑内机制和传播的理解。该提案的中心假设是,免疫抑制患者的全身性巨细胞病毒感染通过特定机制以可预测的局部模式传播到大脑,并且受到宿主免疫疾病能力的强烈影响。下面描述的研究将确定系统性CMV感染、宿主免疫和CNS疾病的关系。将使用导致嗜神经性CMV感染的胃肠外CMV接种的新型小鼠模型,通过4种主要策略来检验该假设:1)确定小鼠免疫缺陷的严重程度是否改变对嗜神经性CMV传播的易感性,2)确定CNS的CMV感染是否可以通过游离病毒、感染的白细胞的血行性传播或直接通过轴突内运输至脑而发生,3)确定小鼠是否通过特异性免疫淋巴样细胞群的过继转移而免受嗜神经性MCMV的影响,确定免疫或非特异性免疫T细胞的过继转移是否可以减少或清除已建立的CMV脑炎。这一建议阐明了嗜神经性CMV作为一种主要的机会性CNS病原体的意义,而没有混杂变量,如同时发生的HIV复制,并可能有助于推进CMV相关脑炎和艾滋病痴呆综合征的诊断和治疗。该提案所固有的培训将扩展,拓宽和加深我对传染病发病机制的知识,并培养对我的科学独立至关重要的免疫调节方面的智力和技术能力。培训将在耶鲁大学医学院进行,由神经外科教授Anthony货车den Pol博士和高级神经科学家Nancy Ruddle博士指导,Nancy Ruddle博士是流行病学和公共卫生/免疫生物学和微生物疾病流行病学教授,世界级免疫学家,与Akiko Iwasaki博士合作,流行病学/公共卫生助理教授,在宿主对感染性微生物的免疫机制方面具有很强的研究资格。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JON David REUTER其他文献
JON David REUTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JON David REUTER', 18)}}的其他基金
Cagewash Renovation for Safety & Long-Term Research Support at The Salk Institute
笼洗改造以确保安全
- 批准号:
8525869 - 财政年份:2013
- 资助金额:
$ 12.85万 - 项目类别:
NEUROTROPIC CYTOMEGALOVIRUS DURING IMMUNOSUPPRESSION
免疫抑制期间的神经营养性巨细胞病毒
- 批准号:
6623054 - 财政年份:2002
- 资助金额:
$ 12.85万 - 项目类别:
NEUROTROPIC CYTOMEGALOVIRUS DURING IMMUNOSUPPRESSION
免疫抑制期间的神经营养性巨细胞病毒
- 批准号:
7066564 - 财政年份:2002
- 资助金额:
$ 12.85万 - 项目类别:
NEUROTROPIC CYTOMEGALOVIRUS DURING IMMUNOSUPPRESSION
免疫抑制期间的神经营养性巨细胞病毒
- 批准号:
6721382 - 财政年份:2002
- 资助金额:
$ 12.85万 - 项目类别:
NEUROTROPIC CYTOMEGALOVIRUS DURING IMMUNOSUPPRESSION
免疫抑制期间的神经营养性巨细胞病毒
- 批准号:
6878624 - 财政年份:2002
- 资助金额:
$ 12.85万 - 项目类别:
相似海外基金
Modulation of T-/B-lymphocyte immigration affects subsequent allograft damage (B06)
T/B 淋巴细胞迁移的调节会影响随后的同种异体移植物损伤 (B06)
- 批准号:
517500221 - 财政年份:2023
- 资助金额:
$ 12.85万 - 项目类别:
CRC/Transregios
development of therapeutic strategy for immune related adverse events by immune checkpoint inhivitor by focusing on B lymphocyte
以B淋巴细胞为重点,制定免疫检查点抑制剂免疫相关不良事件的治疗策略
- 批准号:
22K08541 - 财政年份:2022
- 资助金额:
$ 12.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Role and Regulation of Monocarboxylate Transporters 1 and 4 in Epstein-Barr Virus-mediated B Lymphocyte Tumorigenesis
单羧酸转运蛋白1和4在EB病毒介导的B淋巴细胞肿瘤发生中的作用和调节
- 批准号:
10154328 - 财政年份:2021
- 资助金额:
$ 12.85万 - 项目类别:
Dissecting Hem-1 functions in B lymphocyte Development and Primary Immunodeficiency Disease
剖析 Hem-1 在 B 淋巴细胞发育和原发性免疫缺陷病中的功能
- 批准号:
10385848 - 财政年份:2021
- 资助金额:
$ 12.85万 - 项目类别:
The role of Semaphorin 4C-PlexinB2 interaction in B-lymphocyte differentiation
Semaphorin 4C-PlexinB2 相互作用在 B 淋巴细胞分化中的作用
- 批准号:
RGPIN-2017-06735 - 财政年份:2021
- 资助金额:
$ 12.85万 - 项目类别:
Discovery Grants Program - Individual
The Role and Regulation of Monocarboxylate Transporters 1 and 4 in Epstein-Barr Virus-mediated B Lymphocyte Tumorigenesis
单羧酸转运蛋白1和4在EB病毒介导的B淋巴细胞肿瘤发生中的作用和调节
- 批准号:
10364632 - 财政年份:2021
- 资助金额:
$ 12.85万 - 项目类别:
Functional Consequences of Ubiquitin Depletion During B Lymphocyte Differentiation
B 淋巴细胞分化过程中泛素耗竭的功能后果
- 批准号:
10055003 - 财政年份:2020
- 资助金额:
$ 12.85万 - 项目类别:
Functional Consequences of Ubiquitin Depletion During B Lymphocyte Differentiation
B 淋巴细胞分化过程中泛素耗竭的功能后果
- 批准号:
10684125 - 财政年份:2020
- 资助金额:
$ 12.85万 - 项目类别:
Characterization of B Lymphocyte Deficiency in Pediatric Sickle Cell Disease
儿童镰状细胞病 B 淋巴细胞缺乏的特征
- 批准号:
10641800 - 财政年份:2020
- 资助金额:
$ 12.85万 - 项目类别:
How does aberrant B lymphocyte produce a origin of multiple myeloma cells?
异常B淋巴细胞如何产生多发性骨髓瘤细胞的起源?
- 批准号:
20K08738 - 财政年份:2020
- 资助金额:
$ 12.85万 - 项目类别:
Grant-in-Aid for Scientific Research (C)